Status:

COMPLETED

A Study to Evaluate the Efficacy of VL-NL-02 on Sleep Quality.

Lead Sponsor:

Vedic Lifesciences Pvt. Ltd.

Conditions:

Mood and Sleep Quality

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

The goal of this clinical trial is to study the impact of VL-NL-02 in improving sleep quality, restorative sleep complaints, quality of life, stress levels, and sleep stages. 48 participants are expe...

Eligibility Criteria

Inclusion

  • Individuals aged between ≥ 18 and ≤ 50 years with a moderately active lifestyle as assessed International Physical Activity Questionnaire - Short form (IPAQ - SF)
  • Individuals with mild to moderate sleeping issues as assessed by an ISI score of ≥ 8 and ≤ 21
  • Individuals with a history of at least 3 episodes of sleep disturbances in the last month.
  • Individuals with a Fasting Blood glucose (FBG) ≤ 125 mg/dl
  • All individuals who are free from use of sleeping pills for at least 4 weeks before screening
  • Individuals with normal levels of laboratory parameters: Liver profile, Lipid profile and kidney profile. \[Refer to section 3.7.3 for details on parameters included and reference ranges.\]
  • Individuals with no more than once per week use of pain-relieving medications.
  • Individuals with body mass index between ≥18 and ≤ 30 kg/m2.
  • Typical bedtime between 9 PM and 11 PM.
  • Individuals willing to abstain from digital activity 3 hours prior to the PSG analysis
  • Willing to maintain current dietary pattern, activity level, and stable body weight for the duration of the study, and refrain from any drastic lifestyle changes.

Exclusion

  • FBG \> 125 mg/dl
  • Individuals diagnosed with hypertension.
  • Individuals having a systolic blood pressure ≥140 mm Hg and diastolic blood pressure ≥ 90 mm Hg.
  • Individuals diagnosed with Type I and Type II Diabetes Mellitus.
  • Sleep disorder is secondary to another health problem such as restless leg syndrome, post-operative state etc.
  • Individuals diagnosed with insomnia.
  • Consumption of hypnotic drugs (\<3 months before inclusion)
  • Individuals taking any other sleep promoting supplements and are unwilling to stop taking those supplements for the duration of the study period
  • Individuals with history of sleepwalk
  • Individuals who have bad dreams 2 or more times a week.
  • Individuals who are inclined to the lifestyle factors - such as jet lag, night workers and rotational shift work.
  • Individuals who currently, or in the past 6 months suffered from any mental-health disorder
  • Individuals who were taking psychotropic medication, herbal preparation, antidepressants, steroids, antihistamines, narcotics or any other illicit drugs in the last three months.
  • Individuals diagnosed with chronic medical conditions - such as heart problems, Gastro-intestinal, hepatic, respiratory, psychiatric, kidney, or cardiovascular disorder (\<3 months before inclusion), and chronic pain since last 6 months.
  • Recent (within 3 months before inclusion) change in lifestyle (food, sport and drug).
  • Individuals who are regular smokers and/or consume any form of tobacco.
  • Addiction, history of addiction, and/or substance abuse (tobacco, nicotine etc.).
  • Heavy drinkers as defined by:
  • For men, consuming more than 4 drinks on any day or more than 14 drinks/week
  • For women, consuming more than 3 drinks on any day or more than 7 drinks/week
  • Exaggerated consumption of tea (≥500 mL per day), coffee (≥400 mL per day), or energy drink (≥250 mL per day),
  • Individuals on dietary supplements
  • Pregnant or lactating woman,
  • Lifestyle habits which would modify the wake-sleep rhythm or which was expected to be modified during the study period (e.g., night work)
  • Known allergy to mushroom.

Key Trial Info

Start Date :

December 4 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2024

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT06056258

Start Date

December 4 2023

End Date

April 1 2024

Last Update

January 28 2025

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

BAJ RR Hospital

Dombivali, Maharashtra, India, 421203

2

Surya Multispeciality Hospital

Nashik, Maharashtra, India, 422003

3

Sparsh Hospital

Navi Mumbai, Maharashtra, India, 410206

4

Dhanwantari Hospital

Pune, Maharashtra, India, 411011